191 related articles for article (PubMed ID: 37238630)
1. Homogeneous, Synthetic, Non-Saccharide Glycosaminoglycan Mimetics as Potent Inhibitors of Human Cathepsin G.
Afosah DK; Fayyad RM; Puliafico VR; Merrell S; Langmia EK; Diagne SR; Al-Horani RA; Desai UR
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238630
[TBL] [Abstract][Full Text] [Related]
2. Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G.
Ledoux D; Merciris D; Barritault D; Caruelle JP
FEBS Lett; 2003 Feb; 537(1-3):23-9. PubMed ID: 12606025
[TBL] [Abstract][Full Text] [Related]
3. Sulphated penta-galloyl glucopyranoside (SPGG) is glycosaminoglycan mimetic allosteric inhibitor of cathepsin G.
Al-Horani RA; Afosah DK; Kar S; Aliter KF; Mottamal M
RPS Pharm Pharmacol Rep; 2023 Jan; 2(1):rqad001. PubMed ID: 36844783
[TBL] [Abstract][Full Text] [Related]
4. Potent, Selective, Allosteric Inhibition of Human Plasmin by Sulfated Non-Saccharide Glycosaminoglycan Mimetics.
Afosah DK; Al-Horani RA; Sankaranarayanan NV; Desai UR
J Med Chem; 2017 Jan; 60(2):641-657. PubMed ID: 27976897
[TBL] [Abstract][Full Text] [Related]
5. Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G.
Aliter KF; Al-Horani RA
Med Chem; 2024 Apr; ():. PubMed ID: 38676528
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin.
Baici A; Diczházi C; Neszmélyi A; Móczár E; Hornebeck W
Biochem Pharmacol; 1993 Nov; 46(9):1545-9. PubMed ID: 8240409
[TBL] [Abstract][Full Text] [Related]
7. Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense.
Tausch L; Henkel A; Siemoneit U; Poeckel D; Kather N; Franke L; Hofmann B; Schneider G; Angioni C; Geisslinger G; Skarke C; Holtmeier W; Beckhaus T; Karas M; Jauch J; Werz O
J Immunol; 2009 Sep; 183(5):3433-42. PubMed ID: 19648270
[TBL] [Abstract][Full Text] [Related]
8. Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile.
Al-Horani RA; Karuturi R; Lee M; Afosah DK; Desai UR
PLoS One; 2016; 11(7):e0160189. PubMed ID: 27467511
[TBL] [Abstract][Full Text] [Related]
9. N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3.
Craciun I; Fenner AM; Kerns RJ
Glycobiology; 2016 Jul; 26(7):701-709. PubMed ID: 26850997
[TBL] [Abstract][Full Text] [Related]
10. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G.
Pratt CW; Tobin RB; Church FC
J Biol Chem; 1990 Apr; 265(11):6092-7. PubMed ID: 2318847
[TBL] [Abstract][Full Text] [Related]
11. Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human Cathepsin G.
Sissi C; Lucatello L; Naggi A; Torri G; Palumbo M
Biochem Pharmacol; 2006 Jan; 71(3):287-93. PubMed ID: 16310171
[TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis Lung Disease.
Voynow JA; Zheng S; Kummarapurugu AB
Front Pharmacol; 2020; 11():1011. PubMed ID: 32733248
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of cathepsin G: a patent review (2005 to present).
Kosikowska P; Lesner A
Expert Opin Ther Pat; 2013 Dec; 23(12):1611-24. PubMed ID: 24079661
[TBL] [Abstract][Full Text] [Related]
14. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.
Burster T; Macmillan H; Hou T; Schilling J; Truong P; Boehm BO; Zou F; Lau K; Strohman M; Schaffert S; Busch R; Mellins ED
Immunology; 2010 Jul; 130(3):436-46. PubMed ID: 20331476
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation.
Burgener SS; Leborgne NGF; Snipas SJ; Salvesen GS; Bird PI; Benarafa C
Cell Rep; 2019 Jun; 27(12):3646-3656.e5. PubMed ID: 31216481
[TBL] [Abstract][Full Text] [Related]
16. Sulfonated Nonsaccharide Heparin Mimetics Are Potent and Noncompetitive Inhibitors of Human Neutrophil Elastase.
Al-Horani RA; Aliter KF; Kar S; Mottamal M
ACS Omega; 2021 May; 6(19):12699-12710. PubMed ID: 34056422
[TBL] [Abstract][Full Text] [Related]
17. On the Process of Discovering Leads That Target the Heparin-Binding Site of Neutrophil Elastase in the Sputum of Cystic Fibrosis Patients.
Morla S; Sankaranarayanan NV; Afosah DK; Kumar M; Kummarapurugu AB; Voynow JA; Desai UR
J Med Chem; 2019 Jun; 62(11):5501-5511. PubMed ID: 31074986
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand.
Stoller ML; Basak I; Denorme F; Rowley JW; Alsobrooks J; Parsawar K; Nieman MT; Yost CC; Hamilton JR; Bray PF; Campbell RA
Blood Adv; 2022 Apr; 6(7):2303-2308. PubMed ID: 34883511
[TBL] [Abstract][Full Text] [Related]
20. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells.
Reich M; Lesner A; Legowska A; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
Mol Immunol; 2009 Sep; 46(15):2994-9. PubMed ID: 19615749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
